A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder
Clinical trial NCT05733546 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05733546
- Sponsor
- COMPASS Pathways
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-30
- Primary completion
- 2025-09-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.